Trademark applications and grants for Mirum Pharmaceuticals Inc. Mirum Pharmaceuticals Inc has 17 trademark applications. The latest application filed is for "CTEXLI"
Patent Application | Date |
---|---|
METHODS FOR TREATING CHOLESTASIS 20220160726 - 17/430210 JAECKLIN; Thomas ;   et al. | 2022-05-26 |
METHODS FOR INCREASING GROWTH IN PEDIATRIC SUBJECTS HAVING CHOLESTATIC LIVER DISEASE 20220152022 - 17/430168 JAECKLIN; Thomas ;   et al. | 2022-05-19 |
GENOTYPE AND DOSE-DEPENDENT RESPONSE TO AN ASBTI IN PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY 20220133738 - 17/430125 JAECKLIN; Thomas ;   et al. | 2022-05-05 |
METHODS FOR TREATING CHOLESTASIS 20220105092 - 17/554588 Jaecklin; Thomas ;   et al. | 2022-04-07 |
METHODS FOR TREATING CHOLESTASIS 20210113585 - 17/119132 Jaecklin; Thomas | 2021-04-22 |
SEC | 0001759425 | Mirum Pharmaceuticals, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.